3-D Matrix, Ltd.

Tokyo Stock Exchange 7777.T

3-D Matrix, Ltd. EBITDA for the year ending April 30, 2024: USD 13.25 M

3-D Matrix, Ltd. EBITDA is USD 13.25 M for the year ending April 30, 2024, a 152.63% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

3-D Matrix, Ltd. EBITDA for the year ending April 30, 2023 was USD 5.25 M, a -19.17% change year over year.
3-D Matrix, Ltd. EBITDA for the year ending April 30, 2022 was USD 6.49 M, a 11.28% change year over year.
3-D Matrix, Ltd. EBITDA for the year ending April 30, 2021 was USD 5.83 M, a 211.83% change year over year.
3-D Matrix, Ltd. EBITDA for the year ending April 30, 2020 was USD -5.22 M, a -104.01% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

Tokyo Stock Exchange: 7777.T

3-D Matrix, Ltd.

CEO	Mr. Jun Okada
IPO Date	Oct. 24, 2011
Location	Japan
Headquarters	Kojimachi HF Building
Employees	106
Sector	Health Care
Industries Biotechnology 3D Printing Chemicals & Advanced Materials Pharmaceuticals

Description

3-D Matrix, Ltd. develops self-assembling peptide technology. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the fields of regenerative medicine, cell therapy, drug delivery technology, and surgical treatment. The company was founded in 2004 and is based in Tokyo, Japan.

Key trends

Past 5 years